In a pairwise comparison, while the COVID-19-positive group had statistically significantly higher IL-34 levels compared to the control group (p<0.05), there was no statistically significant difference between the IL-34 levels of the COVID-19-positive groups (ICU or outpatient) (p > 0.05) (Fig 1). The gene discussed is IL34; the disease is COVID-19.